Practical Diabetology is a professional journal providing busy physicians with straightforward, practical information to enhance the care and treatment they give their diabetes patients. Articles concern all aspects of diabetes and its complications and are designed to be quickly read, easily understood, and readily incorporated into daily practice.

To browse our archive or search for articles by subject, see the archive or subject index page. Two Minutes With Diabetes offers brief and instructive case studies on common problems arising in diabetes care.

Current Issue

Volume 36, Number 1 (March/April)

Community Gardening for Patients With Diabetes Mellitus in an Underserved Community: A Pilot Study (pages 4-9)

Pratima R. Nayak, M.D., Jie Hu, Ph.D., R.N., F.A.A.N., Elizabeth A. Snyder, R.D., L.D., C.D.E., Natalie M. Stephens, R.D., Sarah A. Jonaus, M.D., Steven W. Ing, M.D., The Ohio State University Wexner Medical Center, Columbus, OH

Multiple barriers to optimal diabetes management and control exist due to the disease’s complexities, which are particularly apparent in underserved communities. Participation in a community garden is generally thought to confer social, mental, and physical health benefits. The purpose of this study was to explore the impact of community gardening on health outcomes related to diabetes mellitus.
Diabetes in specific populationsUnderserved

The Benefits of Peer Support for Parents of Children With Type 1 Diabetes (pages 10-12)

Elisa Brier Cruz, Licensed Clinical Psychologist, Bronx, NY; M.S. Candidate, Diabetes Education and Management, Teachers College, Columbia University

Given the intensive and complex demands of caring for children with Type 1 diabetes, the notable levels of psychological distress experienced by many parents, which can ebb and flow with changing demands, are not surprising. However, the same complex demands can make it easy for health-care providers to overlook parents’ emotional needs as they first address pressing or overt medical concerns. Directly questioning parents about their emotional well-being and that of their children and family as a whole can help identify those who may benefit from connecting with trusted sources of peer support. If in-house systems are not in place to make such connections, there are a plethora of large, reputable resources that can be shared. Access to such support can help parents cope with the emotional manifestations and practical challenges of their new job and empower them to meet its at times overwhelming demands.
Childhood diabetes

Journal Watch (pages 13-14)

Kathleen Wyne, M.D., Ph.D.

This column highlights recent clinical trial data and landmark clinical trials to provide readers with relevant information and links for obtaining trial data and articles to facilitate discussions with patients and other providers. It features the results of four trials: A Multicenter, Randomized, Double-Blind, Parallel- Group Study Comparing the Efficacy and Safety of Clonidine Topical Gel, 0.1% with Placebo in the Management of Pain Associated with Painful Diabetic Neuropathy A Multicenter, Randomized, Double Blind, Parallel- Group Study Comparing the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1%, to Clonidine Hydrochloride Gel Comparator in the Management of Painful Diabetic Neuropathy A Multicenter Randomized, Double-Blind, Placebo- Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated with Painful Diabetic Neuropathy A Multicenter, Open-Label, Single-Arm Study to Evaluate the Long-Term Use of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated with Painful Diabetic Neuropathy
Clinical trials

Fixed Dose Combinations (FDCs): From Orals to Injectables (pages 15-17)

Kathleen Wyne, M.D., Ph.D.

Fixed Dose Combinations (FDCs) were first approved in the U.S. in 2000 with the glyburide/metformin combination called Glucovance®. Initially, many physicians opposed the use of FDCs because they felt they prevented our ability to optimally titrate the doses of either medication. One argument used to counter that was data showing compliance improved with decreased frequency of dosing (i.e., daily rather than BID) and with a decreased number of pills. However, the success of that initial glyburide/metformin formulation at improving glucose control led to rapid adoption of an FDC as part of our armamentarium. Interestingly, that formulation utilized a micronized glyburide that was significantly different from prior formulations and may have been one of the reasons this specific FDC was so successful.
Drug treatmentMetformin
Drug treatmentSulfonylureas